Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing
BPC-157 addresses this directly through robust angiogenic effects mediated by the VEGFR2-Akt-eNOS pathway and nitric oxide production
Katrin Svensson, PhD, an associate professor of pathology at Stanford University who directs a lab doing preclinical peptide research, goes further
Storage Instructions Store in a cool, dry place away from direct sunlight Keep out of reach of children Do not use after the expiry date mentioned on the pack Safety Information Read the label carefully before use Do not exceed the recommended dosage Consult your doctor if you are pregnant, nursing, or have any medical conditions Discontinue use and consult a physician if any adverse reaction occurs Side Effects Side effects are rare when used as directed
Hellinger R, Sigurdsson A, Wu W, Romanova EV, Li L, Sweedler JV
Ethics statement The animal study was reviewed and approved by the Ethics Committee School of Medicine, the University of Zagreb